Research ArticleBRAIN
MR Contrast Media in Neuroimaging: A Critical Review of the Literature
Jonathan Breslau, Jeffrey G. Jarvik, David R. Haynor, W. T. Longstreth Jr, Daniel L. Kent and Kenneth R. Maravilla
American Journal of Neuroradiology April 1999, 20 (4) 670-675;
Jonathan Breslau
Jeffrey G. Jarvik
David R. Haynor
W. T. Longstreth Jr
Daniel L. Kent
Appendix — Articles reviewed:
- Albert FK, Forsting M, Sartor K, Adams HP, Kunze S. Early postoperative magnetic resonance imaging after resection of malignant glioma: objective evaluation of residual tumor and its influence on regrowth and prognosis. Neurosurgery 1994;34:45-60
- Allen ED, Byrd SE, Darling CF, Tomita T, Wilczynski MA. The clinical and radiological evaluation of primary brain neoplasms in children, part II: radiological evaluation. J Natl Med Assoc 1993;85:546-553
- Aslanian V, Lemaignen H, Bunouf P, Svaland MG, Borseth A, Lundby B. Evaluation of the clinical safety of gadodiamide injection, a new nonionic MRI contrast medium for the central nervous system: a European perspective. Neuroradiology 1996;38:537-541
- Baierl P, Muhlsteffen A, Haustein J, et al. Comparison of plain and Gd-DTPA–enhanced MR-imaging in children. Pediatr Radiol 1990;20:515-519
- Ball WSJ, Parker JR, Davis PC, Glasier CM, Morris MR. Efficacy of gadoteridol for contrast-enhanced magnetic resonance imaging in children. Invest Radiol 1992;27:S45-S52
- Ball WSJ, Nadel SN, Zimmerman RA, et al. Phase III multicenter clinical investigation to determine the safety and efficacy of gadoteridol in children suspected of having neurologic disease. Radiology 1993;186:769-774
- Bauer WM, Fenzl G, Vogl T, Fink U, Lissner J. Indications for the use of Gd-DTPA in MRI of the central nervous system: experiences in patients with cerebral and spinal diseases. Invest Radiol 1988;23(Suppl):S286-S288
- Burke JW, Podrasky AE, Bradley WG. Meninges: benign postoperative enhancement on MR images. Radiology 1990;174:99-102
- Carvlin MJ, DeSimone DN, Meeks MJ. Phase II clinical trial of gadoteridol injection, a low-osmolal magnetic resonance imaging contrast agent. Invest Radiol 1992;27:S16-S21
- Chong VFH, Fan Y, Khoo JBK. Nasopharyngeal carcinoma with intracranial spread: CT and MR characteristics. J Comput Assist Tomogr 1996;20:563-569
- Davis PC, Hudgins PA, Peterman SB, Hoffman JCJ. Diagnosis of cerebral metastases: double-dose delayed CT vs. contrast-enhanced MR imaging. AJNR Am J Neuroradiol 1991;12:293-300
- Debatin JF, Nadel SN, Gray L, et al. Phase III clinical evaluation of gadoteridol injection: experience in pediatric neuro-oncologic MR imaging. Pediatr Radiol 1992;10:101-108
- DeSimone D, Morris M, Rhoda C, et al. Evaluation of the safety and efficacy of gadoteridol injection (a low osmolal magnetic resonance contrast agent): clinical trials report. Invest Radiol 1991;26:S212-S216
- Ekholm S, Jonsson E, Sandvik L, et al. Tolerance and efficacy of omniscan (gadodiamide injection) in MR imaging of the central nervous system. Acta Radiol 1996;37:223-228
- Eldevik OP, Brunberg JA. Gadopentetate dimeglumine-enhanced MR of the brain: clinical utility and safety in patients younger than two years of age. AJNR Am J Neuroradiol 1994;15:1001-1008
- Elster AD, Rieser GD. Gd-DTPA–enhanced cranial MR imaging in children: initial clinical experience and recommendations for its use. AJR Am J Roentgenol 1989;153:1265-1268
- Elster AD, Moody DM, Ball MR, Laster DW. Is Gd-DTPA required for routine cranial MR imaging? Radiology 1989;173:231-238
- Elster AD, DiPersio DA. Cranial postoperative site: assessment with contrast-enhanced MR imaging. Radiology 1990;174:93-98
- Elster AD, Moody DM. Early cerebral infarction: gadopentetate dimeglumine enhancement. Radiology 1990;177:627-632
- Elster AD. MR contrast enhancement in brainstem and deep cerebral infarction. AJNR Am J Neuroradiol 1991;12:1127-1132
- Elster AD, Mirza W. MR imaging in chronic partial epilepsy: role of contrast enhancement. AJNR Am J Neuroradiol 1991;12:165-170
- Fazekas F, Fazekas G, Schmidt R, Kapeller P, Offenbacher H. Magnetic resonance imaging correlates of transient ischemic attacks. Stroke 1996;27:607-611
- Felix R, Schorner W, Laniado M, et al. Brain tumors: MR imaging with gadolinium-DTPA. Radiology 1985;156:681-688
- Filling-Katz MR, Choyke PL, Patronas NJ, et al. Radiologic screening for vonHippel-Lindau disease: the role of Gd-DTPA enhanced MR imaging of the CNS. J Comput Assist Tomogr 1989;13:743-755
- Filling-Katz MR, Choyke PL, Oldfield E, et al. Central nervous system involvement in vonHippel-Lindau disease. Neurology 1991;41:41-46
- Fischbein NJ, Prados MD, Wara W, Russo C, Edwards MSB, Barkovich AJ. Radiological classification of brain stem tumors: correlation of magnetic resonance imaging appearance with clinical outcome. Pediatr Neurosurg 1996;24:9-23
- Frank JA, Bash C, Stone L, Petrella J, Maloni H, McFarland H. . Acad Radiol 1996;3:S173-S175
- Ge HL, Hirsch WL, Wolf GL, Rubin RA, Hackett RK. Diagnostic role of gadolinium-DTPA in pediatric neuroradiology: a retrospective review of 655 cases. Neuroradiology 1992;34:122-125
- Grane P, Tullberg T, Rydberg J, Lindgren L. Postoperative lumbar MR imaging with contrast enhancement: comparison between symptomatic and asymptomatic patients. Acta Radiol 1996;37:366-372
- Greco A, McNamara MT, Lanthiez P, Quay SC, Michelozzi G. Gadodiamide injection: nonionic gadolinium chelate for MR imaging in the brain and spine: phase II–III clinical trial. Radiology 1990;176:451-456
- Haughton VM, Rimm AA, Czervionke LF, et al. Sensitivity of Gd-DTPA–enhanced MR imaging of benign extraaxial tumors. Radiology 1988;166:829-833
- Haustein J, Laniado M, Niendorf HP, et al. Administration of gadopentetate dimeglumine in MR imaging of intracranial tumors: dosage and field strength. AJNR Am J Neuroradiol 1992;13:1199-1206
- Haustein J, Laniado M, Niendorf HP, et al. Triple-dose versus standard-dose gadopentetate dimeglumine: a randomized study in 199 patients. Radiology 1993;186:855-860
- Hesselink JR, Dunn WM, Healy ME, Hajek P, Baker L, Brahme FJ. Paramegnetic enhancement of cerebral lesions with gadolinium-DTPA. Acta Radiol Suppl Stockh 1986;369:558-560
- Hesselink JR, Healy ME, Press GA, Brahme FJ. Benefits of Gd-DTPA for MR imaging of intracranial abnormalities. J Comput Assist Tomogr 1988;12:266-274
- Hudgins PA, Davis PC, Hoffman JCJ. Gadopentetate dimeglumine-enhanced MR imaging in children following surgery for brain tumor: spectrum of meningeal findings. AJNR Am J Neuroradiol 1991;12:301-307
- Hueftle MG, Modic MT, Ross JS, et al. Lumbar spine: postoperative MR imaging with Gd-DTPA. Radiology 1988;167:817-824
- Jackler RK, Shapiro MS, Dillon WP, Pitts L, Lanser MJ. Gadolinium-DTPA enhanced magnetic resonance imaging in acoustic neuroma diagnosis and management. Otolaryngol Head Neck Surg 1990;102:670-677
- Jinkins JR, Osborn AG, Garrett DJ, Hunt S, Story JL. Spinal nerve enhancement with Gd-DTPA: MR correlation with the postoperative lumbosacral spine. AJNR Am J Neuroradiol 1993;14:383-394
- Kaplan GD, Aisen AM, Aravapalli SR. Preliminary clinical trial of gadodiamide injection: a new nonionic gadolinium contrast agent for MR imaging. J Magn Reson Imaging 1991;1:57-62
- Kilgore DP, Breger RK, Daniels DL, Pojunas KW, Williams AL, Haughton VM. Cranial tissues: normal MR appearance after intravenous injection of Gd-DTPA. Radiology 1986;160:757-761
- Kucharczyk W, Lee DH, McClarty B, Robertson WD, Hele MJ. Routine contrast enhancement for cranial magnetic resonance imaging: an analysis of its diagnostic value in adults. Can Assoc Radiol J 1991;42:199-209
- Martin N, Sterkers O, Nahum H. Chronic inflammatory disease of the middle ear cavities: Gd-DTPA–enhanced MR imaging. Radiology 1990;176:399-405
- Menor F, Marti BL, Mulas F, Poyatos C, Cortina H. Neuroimaging in tuberous sclerosis: a clinicoradiological evaluation in pediatric patients. Pediatr Radiol 1992;22:485-489
- Meyers SP, Wildenhain S, Chess MA, Tarr RW. Postoperative evaluation for intracranial recurrence if medulloblastoma: MR findings with gadopentetate dimeglumine. AJNR Am J Neuroradiol 1994;15:1425-1434
- Moghrabi A, Kerby T, Tien RD, Friedman HS. Prognostic value of contrast-enhanced magnetic resonance imaging in brainstem gliomas. Pediatr Neurosurg 1995;23:293-298
- Morikawa M, Sato S, Numaguchi Y, Mihara F, Rothman MI. Spinal epidural venous plexus: its MR enhancement patterns and their clinical significance. Radiat Med 1996;14:221-227
- Muller W, Kramer G, Roder RG, Kuhnert A. Balance of T1-weighted images before and after application of a paramagnetic substance (Gd-DTPA). Neurosurg Rev 1987;10:117-122
- Myhr G, Rinck PA, Borseth A. Gadodiamide injection and gadopentetate dimeglumine: a double-blind study in MR imaging of the CNS. Acta Radiol 1992;33:405-409
- Nelson DR, Yuh WT, Waziri MH, et al. MR imaging of Hippel-Lindau disease: value of gadopentetate dimeglumine. J Magn Reson Imaging 1991;1:469-476
- Niendorf HP, Felix R, Laniado M, Schorner W, Kornmesser W, Claussen C. Magnetic resonance imaging of intracranial tumors using gadolinium-DTPA: initial experience with fast imaging. Acta Radiol Suppl Stockh 1986;369:561-563
- Nishimura R, Takahashi M, Morishita S, Sumi M, Uozumi H, Sakamoto Y. MR Gd-DTPA enhancement of radiation brain injury. Radiat Med 1992;10:109-116
- Nishimura R, Takahashi M, Morishita S, Sumi M, Uozumi H, Sakamoto Y. MR imaging of late radiation brain injury. Radiat Med 1992;10:101-108
- Parizel PM, Baleriaux D, Rodesch G, et al. Gd-DTPA–enhanced MR imaging of spinal tumors. AJR Am J Roentgenol 1989;152:1087-1096
- Post MJ, Sze G, Quencer RM, Eismont FJ, Green BA, Gahbauer H. Gadolinium-enhanced MR in spinal infection. J Comput Assist Tomogr 1990;14:721-729
- Powers TA, Partain CL, Kessler RM, et al. Central nervous system lesions in pediatric patients: Gd-DTPA–enhanced MR imaging. Radiology 1988;169:723-726
- Quint DJ, Eldevik OP, Cohen JK. Magnetic resonance imaging of normal meningeal enhancement at 1.5 T. Acad Radiol 1996;2:463-468
- Rahmouni A, Divine M, Mathieu D, et al. Detection of multiple myeloma involving the spine: efficacy of fat-suppression and contrast-enhanced MR imaging. AJR Am J Roentgenol 1993;160:1049-1052
- Robinson DA, Steiner RE, Young IR. The MR contribution after CT demonstration of supratentorial mass effect without additional localising features. J Comput Assist Tomogr 1988;12:275-279
- Rollins N, Mendelsohn D, Mulne A, et al. Recurrent medulloblastoma: frequency of tumor enhancement on Gd-DTPA MR imaging. AJR Am J Roentgenol 1990;155:153-157
- Ross JS, Modic MT, Masaryk TJ. Tears of the anulus fibrosus: assessment with Gd-DTPA–enhanced MR imaging. AJNR Am J Neuroradiol 1989;10:1251-1254
- Ross JS, Masaryk TJ, Schrader M, Gentili A, Bohlman H, Modic MT. MR imaging of the postoperative lumbar spine: assessment with gadopentetate dimeglumine. AJNR Am J Neuroradiol 1990;11:771-776
- Ross JS, Modic MT, Masaryk TJ, Carter J, Marcus RE, Bohlman H. Assessment of extradural degenerative disease with Gd-DTPA–enhanced MG imaging: correlation with surgical and pathological findings. AJR Am J Roentgenol 1990;154:151-157
- Runge VM, Schaible TF, Goldstein HA, et al. Gd DTPA: clinical efficacy. Radiographics 1988;8:147-159
- Runge VM, Bradley WG, Brant-Zawadzki M, et al. Clinical safety and efficacy of gadoteridol: a study in 411 patients with suspected intracranial and spinal disease. Radiology 1991;181:701-709
- Runge VM, Dean B, Lee C, Carolan F, Heard G. Phase III clinical evaluation of Gd-HP-DO3A in head and spine disease. J Magn Reson Imaging 1991;1:47-56
- Runge VM, Bronen RA, Davis KR. Efficacy of gadoteridol for magnetic resonance imaging of the brain and spine. Invest Radiol 1992;27:522-532
- Russell EJ, Schaible TF, Dillon W, et al. Multicenter double-blind placebo-controlled study of gadopentetate as an MR contrast agent: evaluation in patients with cerebral lesions. AJR Am J Roentgenol 1989;152:813-823
- Sanders WP, Silbergleit R, Spickler EM, Barkley GL, Mehta BA. Efficacy of gadolinium administration in magnetic resonance imaging screening of patients with complex partial seizures and results of a normal neurologic examination. Invest Radiol 1995;30:634-637
- Sartoretti-Schefer Idiopathic, herpetic and HIV-associated facial nerve palsies: abnormal MR enhancement patterns. AJNR Am J Neuroradiol 1994;15:479-485
- Schorner W, Schubeus P, Henkes H, Lanksch W, Felix R. “Meningeal sign”: a characteristic finding of meningiomas on contrast-enhanced MR images. Neuroradiology 1990;32:90-93
- Schroth G, Grodd W, Guhl L, Grauer M, Klose U, Niendorf HP. Magnetic resonance imaging in small lesions of the central nervous system: improvement by gadolinium-DTPA. Acta Radiol 1987;28:667-672
- Schubeus P, Schorner W, Haustein J. Dosing of Gd-DTPA in MR imaging of intracranial tumors. Magn Reson Med 1991;22:249-254
- Schwaighofer BW, Klein MV, Wesbey G, Hesselink JR. Clinical experience with routine Gd-DTPA administration for MR imaging of the brain. J Comput Assist Tomogr 1990;14:11-17
- Seiderer M. Phase III clinical studies with gadoteridol for the evaluation of neurologic pathology: a European perspective. Invest Radiol 1992;27:533-538
- Sharif HS, Clark DC, Aabed MY, et al. Granulomatous spinal infections: MR imaging. Radiology 1990;177:101-107
- Sherman JL, Stern BJ. Sarcoidosis of the CNS: comparison of unenhanced and enhanced MR images. AJR Am J Roentgenol 1990;155:1293-1301
- Stabler A, Baur A, Bartl R, Munker R, Lamerz R, Reiser MF. Contrast enhancement and quantitative signal analysis in MR imaging of multiple myeloma. AJR Am J Roentgenol 1996;167:1029-1036
- Stabler A, Bellan M, Weiss M, Grtner C, Brossman J, Reiser MF. MR imaging of enhancing intraosseous disk herniation (Schmorl's nodes). AJR Am J Roentgenol 1997;168:933-938
- Stack JP, Antoun NM, Jenkins JP, Metcalfe R, Isherwood J. Gadolinium-DTPA as a contrast agent in magnetic resonance imaging of the brain. Neuroradiology 1988;30:145-154
- Stack JP, Ransden RT, Antoun NM, Lye RH, Isherwood J, Jenkins JP. Magnetic resonance imaging of acoustic neuromas: the role of gadolinium-DTPA. Br J Radiol 1988;61:800-805
- Sze G, Soletsky S, Bronen R, Krol G. MR imaging of the cranial meninges with emphasis on contrast enhancement and meningeal carcinomatosis. AJNR Am J Neuroradiol 1989;10:965-975
- Sze G, Milano E, Johnson C, Heier L. Detection of brain metastases: comparison of contrast-enhanced MR with unenhanced MR and enhanced CT. AJNR Am J Neuroradiol 1990;11:785-791
- Sze G, Brant-Zawadzki M, Haughton VM, et al. Multicenter study of gadodiamide injection as a contrast agent in MR imaging of the brain and spine. Radiology 1991;181:693-699
- Sze G, Brant-Zawadzki M, McNamara MT, et al. Use of the magnetic resonance contrast agent gadodiamide in the central nervous system: results of a multicenter trial. Invest Radiol 1993;28:S49-S55
- Tam JK, Bradley WG, Goergen SK, et al. Patterns of contrast enhancement in the pediatric spine at MR imaging with single- and triple-dose gadolinium. Radiology 1996;198:273-278
- Tas MW, Barkhol F, van Walderveen MAA, Polman CH, Hommes OR, Valk J. The effect of gadolinium on the sensitivity and specificity of MR in the initial diagnosis of multiple sclerosis. AJNR Am J Neuroradiol 1995;16:259-264
- Tuite M, Ketonen L, Kieburtz K, Handy B. Efficacy of gadolinium in MR brain imaging of HIV-infected patients. AJNR Am J Neuroradiol 1993;14:257-263
- Tullberg T, Grane P, Isacson J. Gadolinium-enhanced magnetic resonance imaging of 36 patients one year after lumbar disc resection. Spine 1994;19:176-182
- Tullberg T, Grane P, Rydberg J, Isacson J. Comparison of contrast-enhanced computed tomography and gadolinium-enhanced magnetic resonance imaging one year after lumbar discectomy. Spine 1994;19:183-188
- Valk J, De SRG, Crezee FC, Hazenberg GJ, Thjaha SI. Gadolinium-DTPA in magnetic resonance imaging of the brain. Neurosurg Rev 1987;10:87-92
- Valk J, De SRG, Crezee FC, Hazenberg GJ, Thjaha SI, Nauta JJ. Contrast enhanced magnetic resonance imaging of the brain using gadolinium-DTPA. Acta Radiol 1987;28:659-665
- Weingarten K, Ernst RJ, Jahre C, Zimmerman RD. Detection of residual or recurrent meningioma after surgery: value of enhanced vs. unenhanced MR imaging. AJR Am J Roentgenol 1992;158:645-650
- Wiebe S, Lee DH, Karlik SJ, et al. Serial cranial and spinal cord magnetic resonance imaging in multiple sclerosis. Ann Neurol 1992;32:643-650
- Yousem DM, Patrone PM, Grossman RI. Leptomeningeal metastases: MR evaluation. J Comput Assist Tomogr 1990;14:255-261
- Yuh WT, Crain MR, Loes DJ, Greene GM, Ryals TJ, Sato Y. MR imaging of cerebral ischemia: findings in the first 24 hours. AJNR Am J Neuroradiol 1991;12:621-629
- Yuh WT, Fisher DJ, Engelken JD, et al. MR evaluation of CNS tumors: dose comparison study with gadopentetate dimeglumine and gadoteridol. Radiology 1991;180:485-491
- Yuh WT, Engelken JD, Muhonen MG, Mayr NA, Fisher DJ, Ehrhardt JC. Experience with high-dose gadolinium MR imaging in the evaluation of brain metastases. AJNR Am J Neuroradiol 1992;13:335-345
- Yuh WT. Delineation of gliomas with various doses of MR contrast material. AJNR Am J Neuroradiol 1994;15:983-989
- Yuh WT. Phase III multicenter trial of high-dose gadoteridol in MR evaluation of brain metastases. AJNR Am J Neuroradiol 1994;15:1037-1051
- Zee CS, Segall HD, Destian S, Ahmadi J, Apuzzo ML. MRI of intraventricular cysticercosis: surgical implications. J Comput Assist Tomogr 1993;17:932-939
- Zimmerman RA, Bilaniuk LT, Rebsamen S. Magnetic resonance imaging of pediatric posterior fossa tumors. Pediatr Neurosurg 1992;18:58-64
In this issue
Advertisement
MR Contrast Media in Neuroimaging: A Critical Review of the Literature
Jonathan Breslau, Jeffrey G. Jarvik, David R. Haynor, W. T. Longstreth Jr, Daniel L. Kent, Kenneth R. Maravilla
American Journal of Neuroradiology Apr 1999, 20 (4) 670-675;
Jump to section
Related Articles
- No related articles found.
Cited By...
This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.
More in this TOC Section
Similar Articles
Advertisement